已收盘 05-15 16:00:00 美东时间
-0.290
-4.97%
LENSAR publishes corporate presentation on ALLY robotic laser cataract surgery system LENSAR highlighted growth in recurring revenue, with 12-month trailing recurring revenue at USD 47.37 million, up 12.3%. Revenue for three months ended March 31, 2026 fell 5.2% to USD 13.4 million, while net income
05-08 21:59
LENSAR (NASDAQ:LNSR) reported quarterly sales of $13.428 million which missed the analyst consensus estimate of $13.450 million by 0.16 percent. This is a 5.16 percent decrease over sales of $14.159 million the same
05-08 19:01
LENSAR, Inc. (Nasdaq: LNSR), a global medical technology company, announced that its first quarter 2026 financial results will be released on May 8, 2026, followed by a conference call and webcast at 8:30 am ET. The company specializes in advanced robotic laser solutions for cataract treatment, including its ALLY Robotic Cataract Laser System™, which integrates AI and dual-modality laser technology to enhance surgical outcomes and efficiency.
04-30 11:00
Tenax Therapeutics (TENX) appointed Thomas R. Staab II as CFo, effective May 11, 2026, replacing interim CFO Thomas McGauley. Staab brings more than 25 years of financial leadership experience in the ...
04-22 19:18
LENSAR ( ($LNSR) ) has issued an update. LENSAR, Inc., a medical device company...
04-16 05:20
On April 10, 2026, Thomas R. Staab, II, Chief Financial Officer of LENSAR, Inc. (the "Company"), notified the Company of his intention to resign from this position, effective May 8, 2026 (the "Transition Date"), to
04-16 04:36
Alcon (ALC) declares CHF 0.28/share dividend. The dividend, subject to shareholders approval, is payable May 7; for shareholders of record May 6; ex-div May 6. See ALC Dividend Scorecard, Yield Chart,...
04-06 20:46
Lensar Inc (($LNSR)) has held its Q4 earnings call. Read on for the main highli...
04-02 08:21
Companies Reporting Before The Bell • Bitfarms (NASDAQ:BITF) is projected to re...
03-31 19:11